126 related articles for article (PubMed ID: 2777728)
1. Gentamicin and low dose piperacillin in febrile neutropenic patients.
Boughton BJ; Harris RI; Brown RM; Webberley J; Baglin TP; Jackson N; Girling AJ
J Antimicrob Chemother; 1989 Jul; 24(1):45-51. PubMed ID: 2777728
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Kelsey SM; Weinhardt B; Collins PW; Newland AC
Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):509-14. PubMed ID: 1388120
[TBL] [Abstract][Full Text] [Related]
3. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
Kelsey SM; Weinhardt B; Pocock CE; Shaw E; Newland AC
J Chemother; 1992 Oct; 4(5):281-5. PubMed ID: 1336043
[TBL] [Abstract][Full Text] [Related]
5. [Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases].
Murase T
Kansenshogaku Zasshi; 1992 Feb; 66(2):121-6. PubMed ID: 1402071
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
Leyland MJ; Bayston KF; Cohen J; Warren R; Newland AC; Bint AJ; Cefai C; White DG; Murray SA; Bareford D
J Antimicrob Chemother; 1992 Dec; 30(6):843-54. PubMed ID: 1289359
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
González M; Clavell LA
P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Chan CC; Oppenheim BA; Anderson H; Swindell R; Scarffe JH
Antimicrob Agents Chemother; 1989 Jan; 33(1):87-91. PubMed ID: 2653217
[TBL] [Abstract][Full Text] [Related]
10. A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.
Perkkiö M; Hovi L; Rajantie J; Lanning M; Salmi T; Williams K; Mäkipernaa A; Ruuskanen O; Renkonen OV; Herva E
Scand J Infect Dis; 1990; 22(2):209-18. PubMed ID: 2192440
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of latamoxef disodium and gentamicin versus piperacillin and gentamicin in febrile granulocytopenic patients.
O'Brien AJ; Fenelon LE; O'Dwyer R; McCann SR; Daly PA
Br J Clin Pract; 1988 Feb; 42(2):56-60. PubMed ID: 3179173
[No Abstract] [Full Text] [Related]
13. Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Kelsey SM; Shaw E; Newland AC
J Chemother; 1992 Apr; 4(2):107-13. PubMed ID: 1629747
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Griggs JJ; Blair EA; Norton JR; Rowe JM; Flesher WR; Betts RF
Am J Hematol; 1998 Aug; 58(4):293-7. PubMed ID: 9692392
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
[TBL] [Abstract][Full Text] [Related]
16. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
Yamamura D; Gucalp R; Carlisle P; Cimino M; Roberts J; Rotstein C
Antimicrob Agents Chemother; 1997 Aug; 41(8):1704-8. PubMed ID: 9257745
[TBL] [Abstract][Full Text] [Related]
17. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Heney D; Lewis IJ; Ghoneim AT; Chisholm P; Bailey CC
J Antimicrob Chemother; 1991 Jul; 28(1):117-29. PubMed ID: 1769930
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
20. Once-daily versus multiple-daily gentamicin in empirical antibiotic therapy of febrile neutropenia following intensive chemotherapy.
Bakri FE; Pallett A; Smith AG; Duncombe AS
J Antimicrob Chemother; 2000 Mar; 45(3):383-6. PubMed ID: 10702563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
